AUPH
Aurinia Pharmaceuticals Inc
16.60$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -229.9% | – | +7.5% | +76.8% | -95.7% | +3,303.2% | +0.5% | +0.3% | -26.9% | +60.2% | – | |
| – | -5.9% | -2.1% | -0.1% | +1.0% | -0.6% | -0.1% | +0.2% | +0.0% | 0.0% | -48.7% | +93.6% | – | |
| – | -0.3% | -51.2% | +49.7% | -3.0% | +7.4% | -138.1% | – | +8.8% | +13.7% | -112.9% | – | – | |
| – | – | -155.4% | – | -322.1% | – | -211.1% | – | -30.7% | +69.2% | -291.7% | – | – | |
| – | -43.8% | -79.7% | +966.7% | -33.6% | -34.1% | -69.6% | +476.5% | -33.7% | +7.3% | -44.1% | -99.5% | – | |
| – | -68.2% | – | -178.4% | -72.6% | – | -20.9% | -142.8% | +3.8% | +167.8% | -51.0% | – | – | |
| – | – | – | -50.1% | -97.9% | +16,613.0% | +115.2% | -9.3% | -78.8% | – | -2,879.5% | +6.1% | – | |
| – | – | – | – | – | +2.4% | -8.5% | +23.8% | +0.5% | +1.1% | +4.8% | -6.8% | – | |
| – | +139.2% | +169.9% | -45.0% | -67.1% | +746.7% | +114.1% | -10.0% | -76.4% | -95.1% | +10,396.8% | – | – | |
| – | – | +528.9% | -299.3% | – | +1,139.4% | -136.7% | – | – | -65.2% | -658.2% | – | – | |
| – | – | -230.6% | – | +7.8% | +77.4% | -95.7% | +3,340.6% | +0.5% | +0.3% | -26.9% | +60.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.